3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Infections and Inflammatory Heart Diseases
Infections and inflammatory heart diseases can cause significant damage to the heart and its surrounding structures. Conditions such as infective endocarditis, myocarditis, and pericarditis result from bacterial, viral, or fungal infections, leading to inflammation and compromised heart function. Myocarditis, for example, occurs when the heart muscle becomes inflamed due to a viral infection, weakening its ability to pump blood effectively. Inflammatory heart diseases can also arise from autoimmune conditions, where the body's immune system attacks its own tissues, including the heart. Early diagnosis through blood tests, imaging, and clinical evaluation is essential for effective treatment, which may include antibiotics, antivirals, or immunosuppressive therapies. Managing these conditions promptly can reduce the risk of long-term heart damage, including heart failure or valve dysfunction.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation